The research aims to evaluate the effectiveness of topical tacrolimus for treating oral lichen planus, especially in patients with skin involvement.
Retrospective cohort study design
Focus on patients with oral lichen planus and cutaneous involvement
Analysis of treatment outcomes with topical tacrolimus
Topical tacrolimus improved short-term outcomes for oral lichen planus
Particularly effective as a second-line treatment
Showed benefits for patients with skin involvement
Abstract
Topical tacrolimus was associated with improved short-term OLP outcomes and may be particularly useful as a second-line or steroid-sparing option in patients with concomitant cutaneous involvement.